Spots Global Cancer Trial Database for premenopause
Every month we try and update this database with for premenopause cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients | NCT00001837 | Breast Cancer Breast Neoplasm | - | National Institutes of Health Clinical Center (CC) | ||
Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women | NCT00912548 | Breast Cancer | goserelin tamoxifen | 18 Years - 45 Years | Korean Breast Cancer Study Group | |
Effectiveness of DIM Supplements to Increase 2-OHE1/16 Ratio | NCT02525159 | Breast Cancer | DIM pills Placebo Pill | 35 Years - 52 Years | Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes | |
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. | NCT00412022 | Breast Cancer | tamoxifen triptorelin letrozole zoledronic acid | 18 Years - | National Cancer Institute, Naples |